Federal investigators obtained DNA from a mystery juvenile in the Anna Kepner Carnival cruise death case as her stepbrother ...

The team behind Your 3rd Spot is also behind the large food and entertainment business opening next year in downtown Atlanta.

Atrium Health, part of Charlotte, N.C.-based Advocate Health, said a data security incident involving EHR vendor Oracle Health may have exposed patient information tied to legacy systems used before ...

Following the surprise-announcement of a new Horizon multiplayer game recently, it’s now being reported that the next entry in the main series is not anywhere close to release. Bloomberg reporter ...

Atrium Health plans to take control of WakeMed in a deal that could bring at least $2 billion in new investment to Wake County, documents filed with Wake County indicate. It also lets Atrium grow its ...

Authorities are investigating the death of a woman who fell from a balcony aboard a Carnival cruise ship near California’s Catalina Island. The incident happened Monday morning on Carnival Firenze, a ...

Carnival Cruise Line announced Friday that its brand-new ship, the Excel-class Tropicale, will begin sailing from Galveston in spring 2028. Boasting a capacity of about 6,600 passengers and crew, the ...

Federal prosecutors say a 16‑year‑old Florida boy has been indicted as an adult on charges of murder and aggravated sexual abuse in the killing of his stepsister aboard a Carnival cruise ship last ...

South Florida has another day of unsettled weather on deck, with scattered thunderstorms capable of producing very heavy rainfall, particularly along the east c Woman left partially blind in brutal ...

Carnival's ships provide plenty of fun for everyone from kids to adults, with impressive water parks, a variety of dining options, and entertainment venues like comedy spots and nightclubs. Carnival's ...

When Novartis agreed to buy RNA therapies developer Avidity Biosciences last fall, the companies said the plan was to spin out Avidity’s cardiology assets into a separate, publicly traded company.

A new biotech has taken flight as a result of Novartis’ red-hot $12 billion acquisition of muscular dystrophy specialist Avidity Biosciences. A spinout planned since that deal’s October announcement ...